Skip to main content

letter

. 1989 Oct 28;299(6707):1098. doi: 10.1136/bmj.299.6707.1098-a

Cytomegalovirus in blood from blood donors.

M Contreras, J A Barbara, C McDonald

PMCID: PMC1837962 PMID: 2556196

1098

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Diosi P., Moldovan E., Tomescu N. Latent cytomegalovirus infection in blood donors. Br Med J. 1969 Dec 13;4(5684):660–662. doi: 10.1136/bmj.4.5684.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
Peake I. The polymerase chain reaction. J Clin Pathol. 1989 Jul;42(7):673–676. doi: 10.1136/jcp.42.7.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
Preiksaitis J. K., Brown L., McKenzie M. The risk of cytomegalovirus infection in seronegative transfusion recipients not receiving exogenous immunosuppression. J Infect Dis. 1988 Mar;157(3):523–529. doi: 10.1093/infdis/157.3.523. [DOI] [PubMed] [Google Scholar]
Stanier P., Taylor D. L., Kitchen A. D., Wales N., Tryhorn Y., Tyms A. S. Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. BMJ. 1989 Oct 7;299(6704):897–898. doi: 10.1136/bmj.299.6704.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tegtmeier G. E. Transfusion-transmitted cytomegalovirus infections: significance and control. Vox Sang. 1986;51 (Suppl 1):22–30. doi: 10.1111/j.1423-0410.1986.tb01990.x. [DOI] [PubMed] [Google Scholar]
Transfusion-transmitted CMV infections. Clinical importance and means of prevention? Vox Sang. 1984;46(6):387–414. doi: 10.1111/j.1423-0410.1984.tb00103.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES